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Abstract
Background: ASIC3, the most sensitive of the acid-sensing ion channels, depolarizes certain rat sensory
neurons when lactic acid appears in the extracellular medium. Two functions have been proposed for it:
1) ASIC3 might trigger ischemic pain in heart and muscle; 2) it might contribute to some forms of touch
mechanosensation. Here, we used immunocytochemistry, retrograde labelling, and electrophysiology to
ask whether the distribution of ASIC3 in rat sensory neurons is consistent with either of these hypotheses.
Results: Less than half (40%) of dorsal root ganglion sensory neurons react with anti-ASIC3, and the
population is heterogeneous. They vary widely in cell diameter and express different growth factor
receptors: 68% express TrkA, the receptor for nerve growth factor, and 25% express TrkC, the NT3
growth factor receptor. Consistent with a role in muscle nociception, small (<25 µm) sensory neurons
that innervate muscle are more likely to express ASIC3 than those that innervate skin (51% of small muscle
afferents vs. 28% of small skin afferents). Over 80% of ASIC3+ muscle afferents co-express CGRP (a
vasodilatory peptide). Remarkably few (9%) ASIC3+ cells express P2X3 receptors (an ATP-gated ion
channel), whereas 31% express TRPV1 (the noxious heat and capsaicin-activated ion channel also known
as VR1). ASIC3+/CGRP+ sensory nerve endings were observed on muscle arterioles, the blood vessels
that control vascular resistance; like the cell bodies, the endings are P2X3- and can be TRPV1+. The
TrkC+/ASIC3+ cell bodies are uniformly large, possibly consistent with non-nociceptive
mechanosensation. They are not proprioceptors because they fail two other tests: ASIC3+ cells do not
express parvalbumin and they are absent from the mesencephalic trigeminal nucleus.
Conclusion: Our data indicates that: 1) ASIC3 is expressed in a restricted population of nociceptors and
probably in some non-nociceptors; 2) co-expression of ASIC3 and CGRP, and the absence of P2X3, are
distinguishing properties of a class of sensory neurons, some of which innervate blood vessels. We suggest
that these latter afferents may be muscle metaboreceptors, neurons that sense the metabolic state of
muscle and can trigger pain when there is insufficient oxygen.
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Background
ASICs are ion channels that open when the extracellular
pH drops [1,2]. They belong to the epithelial sodium
channel/degenerin superfamily of ion channels [3,4].
Members of this family are selective for sodium, are inhib-
ited by the diuretic drug amiloride, and have two mem-
brane-spanning regions with intracellular N- and C-
termini and a large extracellular loop; multiple subunits
must assemble to form a functional ion channel. There are
three known ASIC genes that can form ion channels and
two splice variants. The mRNA for all these ASICs are
found in sensory ganglia; ASIC3 is unique in that, in
rodents, little or none of it is expressed outside of sensory
neurons [5].
The present study asks whether the distribution of ASIC3
among subsets of sensory neurons is consistent with its
hypothesized roles as a transducer of two distinctly differ-
ent sensations: ischemic pain and mechanosensation.
ASICs were first considered as possible mechanosensitive
ion channels because of their structural similarity to
degenerins, which subserve touch sensitivity in
Caenorhabditis elegans [6]. In rodents, ASICs are expressed
in specific skin mechanosensory endings [7-9] and ASIC
Immunocytochemical localization of ASIC3 in rat sensory neurons Figure 1
Immunocytochemical localization of ASIC3 in rat sensory neurons. A, ASIC3 antibody labeled COS-7 cells trans-
fected with ASIC3 (top), but not those transfected with ASIC1a (bottom). It also failed to label cells transfected with ASIC1b 
and ASIC2a (not shown); ASIC2b and ASIC4 were not tested. B, ASIC3 immunoreactivity in a section of L5 DRG. Less than 
half of neurons are labeled and no non-neurons are labeled. Note the presence of both small and large labeled neurons (inset). 
Scale bar, 40 µm. C, Size-frequency distribution of ASIC3-positive neurons (black) and of all neurons (grey) from the L5 DRG. 
ASIC3+ cells are present in all size bins. 3345 neurons (12–15 sections from 3 rats) were counted, of which 1359 (40%) were 
ASIC3-positive.Molecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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knockout mice exhibit subtle behavioral changes in their
touch sensitivity in some assays [9-11], but not in others
[12,13]. ASIC3 may act as a sensor of the lactic acidosis
that occurs during ischemic pain because: a) it generates
exceedingly large currents in dorsal root ganglion (DRG)
sensory neurons that innervate the heart [14,15], an organ
whose only conscious sensation is ischemic pain
(angina); b) it responds to the small change in extracellu-
lar pH (a drop from 7.4 to 7.0) that occurs in the extracel-
lular space of metabolically stressed muscle [15]; c) it
responds better to lactic acid than to other forms of acid
[16]; d) multiple injections of acid into skeletal muscle
induce a long-lived painful hypersensitivity, but this does
not occur in mice that lack ASIC3 [17]. In contrast to a
possible role in muscle pain, evidence from transgenic
mice argues against ASIC3 directly triggering cutaneous
pain [18], although ASICs appear to contribute to acid-
induced pain in human skin [19,20].
Two prior studies explored ASIC3 immunoreactivity in
sensory neurons. One found ASIC3 and ASIC2 to co-local-
ize in dorsal root ganglion neurons and to be present
more often in larger neurons than in smaller [21]. The
other found ASIC3 in both large and small neurons of the
trigeminal ganglion and to exhibit some co-expression
with CGRP [22]. The present study extends these earlier
ones by combining retrograde labeling, electrophysiology
and immunocytochemistry to distinguish various popula-
tions of nociceptive and non-nociceptive sensory neu-
rons. The results suggest that high ASIC3 expression is an
essential feature of a specific subset of nociceptors that
respond to the metabolic state of muscle, but this is not
the only population of sensory neurons that express
ASIC3.
Results
ASIC3 observed in both TrkA and TrkC-positive neurons
The guinea pig ASIC3 antibody from Neuromics was used
for all staining of dorsal root ganglia (DRG, Figs. 1, 2, 3,
4, 5, 6). We tested its specificity in COS-7 cells transfected
with cDNA for the following ASICs: 1a, 1b, 2a, 3. It
labelled ASIC3-transfected cells but not the others (Fig. 1A
shows ASIC3 and ASIC1a; others are not shown but were
negative like ASIC1a). No staining occurred if the anti-
body was preincubated with antigenic peptide or if the
secondary antibody was applied without the primary (not
ASIC3 co-expression with TrkA and TrkC Figure 2
ASIC3 co-expression with TrkA and TrkC. Photomicrographs of DRG neurons labeled with antibodies to ASIC3 (red) 
and TrkA (A, green) or TrkC (B, green). Double-labeled cells appear yellow or orange. Circle charts show the fraction of dou-
ble labeled cells (yellow), unlabeled (black), ASIC3-only (red), and TrkA or TrkC-only (green). 944 cells counted for A; 832 for 
B. Scale bar, 40 µm.Molecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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shown). The antibody appears free of non-specific stain-
ing at the dilutions we used because it does not label tis-
sue in the brainstem (Fig. 3B), which has no reported
ASIC3 mRNA. Both guinea pig and rabbit anti-ASIC3 were
used to label vascular innervation (Figure 7) and gave
indistinguishable results.
Some 40% (1359/3345 cells in single label studies; 1932/
4783 in double label) of DRG neurons stain for ASIC3
and there is no evident staining in non-neuronal cells or
axon tracts (Fig. 1B). Both small (<25 µm diameter) and
large (>40 µm) diameter sensory neurons express ASIC3.
This contrasts with TRPV1, which is almost exclusively in
smaller neurons [23]. The wide size distribution (Fig. 1C)
suggests that anti-ASIC3 may label neurons that differ in
conduction velocity and perhaps in sensory modality [24-
26].
The TrkA receptor (the binding site for nerve growth fac-
tor) and the TrkC receptor (binding site for NT3 growth
factor) label non-overlapping populations of sensory neu-
rons [27,28]. The majority (68%, 284/417) of ASIC3+
neurons co-expressed TrkA (Fig. 2A). TrkA+ sensory neu-
rons in adult rodents are considered to be NGF-sensitive
nociceptors [29-31].
A minority (25%, 93/373) of ASIC3+ neurons co-
expressed TrkC (Fig. 2B), a growth factor receptor used by
many non-nociceptive mechanosensors [30]. Propriocep-
tors are among the sensory neurons that express TrkC
[32]. Proprioceptors have two other testable properties:
they express parvalbumin [33] and those from mastica-
tory muscles have cell bodies in the brainstem at the mes-
encephalic trigeminal nucleus [34]. Only 2 of 1400
parvalbumin+ neurons co-expressed ASIC3 (Fig. 3A) and
there was no staining in the mesencephalic nucleus (Fig.
3B). Evidently, ASIC3+/TrkC+ cells are not propriocep-
tors.
ASIC3 co-expression with two nociceptive ion channels
To characterize the nociceptive population of neurons
containing ASIC3, we tested for co-expression with two
other ion channels thought to be pain-transducers: P2X3,
an ATP-gated ion channel [35], and TRPV1, the capsaicin
receptor that responds to noxious heat [36]. There was lit-
tle overlap of ASIC3 and P2X3: although many neurons
stained for one or the other, less than 5% (51/1406)
stained strongly for both (Fig. 4A). We used electrophysi-
ological recordings to test for expression of functional
protein; only 10% of cells (18/182) had both ASIC3-like
and P2X3-like currents that were larger than 0.3 nA (Fig.
4C). The cells that co-expressed ASIC3 and P2X3 were all
large (examples: the one orange cell in Fig. 4A, lower left,
and the cell (48 µm diameter) that gave the traces in Fig.
4C). Interestingly, virtually every large P2X3+ cell also
stained positive for ASIC3, suggesting that this may be a
distinct, albeit small population of sensory neurons.
There is more overlap between ASIC3 and TRPV1. 12%
(122/995) of all cells stained for both, and 21% (35/169)
had substantial current carried by both; 31% (122/388) of
ASIC3+ cells were TRPV1+ (Fig. 4B,D). ASIC3/TRPV1 co-
expressors were small (yellow cells, Fig. 4B), unlike the
ASIC3/P2X3 co-expressors.
ASIC3 is not expressed by muscle spindle afferents Figure 3
ASIC3 is not expressed by muscle spindle afferents. 
A, Section of DRG labeled for ASIC3 (red) and for the cal-
cium-binding protein parvalbumin (green), which labels mus-
cle spindle afferents. Only 2 of 1400 parvalbumin-positive 
cells had detectable ASIC3 staining. B, Section of brainstem 
containing a string of sensory neurons in the mesencephalic 
nucleus of the 5th nerve (MesV) stained with either an anti-
body to a neurofilament protein (N52) to reveal all the sen-
sory neurons (left, string of large cells arranged vertically; top 
punctuate labeling are MesV axons in cross section) or with 
the ASIC3 antibody (right). No MesV cells expressed ASIC3 
(n = 3 rats). "IV" marks the fourth ventricle. Scale bars, 40 
µm.Molecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
Page 5 of 13
(page number not for citation purposes)
More ASIC3 expression in small muscle afferents than 
small skin afferents
Although ischemic pain occurs when there is low blood
flow to muscle, low flow to skin occurs routinely without
any pain — for example, for thermoregulation or during
the fight or flight response. Therefore, one might predict
that, if ASIC3 is the sensor for ischemic pain, it should be
in more muscle nociceptors than skin nociceptors. We
tested this prediction by labelling muscle or skin afferents
with retrogradely transported dyes, and then studying
them with either electrical recordings or ASIC3 antibody
staining; diI was used for electrophysiology and fluoro-
gold for immunocytochemistry. In order to focus on noci-
ception, we analyzed data for cells less than 25 µm
diameter. However, as noted before, ASIC3 is also seen in
many large neurons.
Figure 5 shows that small muscle afferents are more likely
to express ASIC3 than are small skin afferents. A stimulus
of pH 6.8, chosen to selectively stimulate ASIC3, elicited
large current (>0.3 nA) in 56% (18/32) of small muscle
afferents, but in only 11% (4/37) of small skin afferents
(Fig. 5B). Immunocytochemistry presents a similar pic-
ture. The arrows in the right images of Fig. 5A point to
small neurons (<25 µm) positive for both ASIC3 (right)
and for fluorogold (left) transported from muscle (upper)
or skin (lower); 50% (57/113) of small muscle afferents
stained for ASIC3, compared to 28% (33/117) of small
skin afferents (Fig. 5B).
ASIC3 and CGRP co-express on sensory endings 
innervating blood vessels
Whether they have small diameters or large, most muscle
afferents (83%, 168/173) that express ASIC3 also express
the vasodilatory peptide, CGRP. The double arrowheads
in the bottom image of Fig. 6 point to cells with evident
nuclei that stained for all three labels: a) fluorogold that
was previously injected into muscle (top panel); b) ASIC3
(middle); and c) CGRP (bottom). The arrows point to
three ASIC3-positive muscle afferents that did not stain
for CGRP. Overlap of CGRP and ASIC3 was also evident
in skin afferents: 69% (168/244) of ASIC3 skin afferents
also stained with the anti-CGRP.
Co-expression of ASIC3 with a vasodilatory peptide sug-
gests that they might be expressed on sensory endings that
innervate vasculature. Fig. 7 shows immunofluorescence
images of arteries within rat lateral plantar muscles using
the rabbit anti-ASIC3. L indicates the artery lumen, TA the
tunica adventitia, and TM the tunica media. Nerve fibers
that express CGRP are from sensory neurons [37]; they are
relatively sparse and are present in the outer, adventitial
layer (TA) of the artery wall (Fig. 7A). Fibers containing
the neuropeptide NPY are from sympathetic neurons [37];
these fibers are denser than the CGRP fibers and lie at the
Most muscle afferents that express ASIC3 also express  CGRP Figure 6
Most muscle afferents that express ASIC3 also 
express CGRP. Three photomicrographs of the same DRG 
section showing: fluorogold transported from a muscle injec-
tion (top); ASIC3 immunoreactivity (middle); CGRP immuno-
reactivity (bottom). Double arrowheads in the bottom image 
indicate cells positive for each label. Arrows indicate cells 
positive for fluorogold and for ASIC3, but not for CGRP. 
83% (168/202) of ASIC3-positive muscle afferents were 
CGRP-positive (373 total muscle afferents counted). Scale 
bar, 40 µm.Molecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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ASIC3 expression compared to other nociceptive ion channels Figure 4
ASIC3 expression compared to other nociceptive ion channels. DRG sections double-labeled for ASIC3 (red) and 
either P2X3 (green, A) or TRPV1 (green, B); double-labeled cells are yellow or orange. Circle charts show the relative distribu-
tion of the three receptors among all DRG neurons. ASIC3 and P2X3 expression overlapped in only 4% of neurons, while 
some 35% of ASIC3-positive neurons also express TRPV1. The rare cells positive for both ASIC3 and P2X3 were large (eg. cell 
at lower left in A). 1406 cells counted for A; 995 for B. C, D, electrophysiological recordings reveal a qualitatively similar 
expression pattern for currents conforming to ASIC3, P2X3, or TRPV1. The cell that generated the currents in C counts as a 
co-expressor of ASIC3 and P2X3, fitting into the yellow bin in the circle plot. The cell in D is a co-expressor of ASIC3 and 
TRPV1. Cells were counted positive if they had at least 0.3 nA of current in response to pH 6.8 (ASIC3+), 50 µM ATP (P2X3+; 
transient current only), or 1 µM capsaicin (TRPV1). 182 cells recorded for C; 169 for D.Molecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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border between the tunica adventitia and tunica media
(TM) parts of the wall (Fig. 7B). Although all of the arterial
innervation has a relatively small caliber, some CGRP-
positive axons are noticeably thicker and are labeled by
anti-200 kD neurofilament protein (NF200) and anti-
myelin basic protein; this indicates that they are myeli-
nated Aδ fibers [37]. The thinner CGRP-positive arterial
innervation lacked NF200 and myelin basic protein
immunoreactivity indicating that they are unmyelinated
C fibers [37].
The ASIC3 antibody labels the thicker CGRP-expressing
fibers in the tunica adventitia (large arrows, Fig. 7E,F) and
it is co-expressed with NF200 (Fig. 7C,D). The thinner
CGRP-expressing axons have little or no detectable ASIC3
immunoreactivity (small arrows, Fig. 7E,F). TRPV1 is also
expressed on at least some of the thicker caliber CGRP-
positive axons (Fig. 7G,H). In contrast to TRPV1 and
ASIC3, antibodies to P2X3 do not label vascular afferents
(not shown). In the adult, vascular CGRP-positive axons
express TrkA but not TrkC [28].
Discussion
We find ASIC3 in less than half of all DRG sensory neu-
rons, but the population is diverse: ASIC3 can be in both
small neurons and large, TrkA-expressors and TrkC. The
neurons fall into at least two distinct subsets: 1) small to
medium-size, TrkA- and CGRP-positive muscle afferents
that lack P2X3 and can innervate small arteries; and 2)
large neurons that lack parvalbumin and can express
either TrkA or TrkC. We discuss the possibilities that neu-
rons in the first subset are muscle metaboreceptors and
the second includes non-proprioceptive mechanosensors.
Metaboreception and the axon reflex
Because ASIC3 can open with quite small (0.5 unit) pH
changes [15] and responds better to lactic acid than to
other acids [16], it seems suitable for detecting when mus-
cle is using anaerobic metabolism. Some consider metab-
oreception to be a subset of nociception [38]. In this view,
low levels of metaboreceptor activity trigger compensa-
tory responses in peripheral tissues and high levels trigger
pain [39-41]. If ASIC3 is a molecular sensor for ischemia,
it should be present in all cardiac DRG afferents (which,
though diverse, all respond to cardiac ischemia, [42]), and
it should be relatively enriched in sensory neurons that
innervate muscle compared to skin because ischemic pain
is characteristic of muscle but not skin. Our data here (on
skin and muscle) and previously (on cardiac afferents,
[14]) fulfill these expectations.
We found profound overlap of ASIC3 and the vasodila-
tory peptide CGRP. Over 80% of ASIC3-positive neurons
that innervate muscle also express CGRP. Importantly,
many sensory axons that innervate small arteries express
ASIC3 together with CGRP and TRPV1. The axons that co-
express the three markers appear to be lightly myelinated
Aδ fibers because they express NF200, a marker of myeli-
nated axons [43], whereas we saw no evidence that CGRP-
positive small-caliber (C) arterial axons express ASIC3 or
TRPV1. These ASIC3/TRPV1/CGRP-positive cells and
axons uniformly fail to express P2X3, the primary ATP-
gated ion channel in sensory neurons. Finally, the pheno-
type seems not to be unique to rats because ASIC3 labe-
ling also occurs on CGRP-positive Aδ fibers that terminate
on small arteries and arterioles in monkeys (Paré and
Rice, unpublished). Extensive overlap of ASIC3 and CGRP
has previously been reported in trigeminal ganglion neu-
rons [22].
Release of CGRP in the periphery clearly contributes to the
"axon reflex", in which activation of C fibers causes
vasodilation and extravasation [44,45]. The tight co-
expression of ASIC3, TRPV1 and CGRP on muscle arterial
afferents raises the possibility that they function together
as sensors and effector, increasing local blood flow in
response to the presence of lactic acid and elevated muscle
temperature. Co-expression of ASIC3 and TRPV1 should
provide a cell with a broad range of acid sensitivity.
These observations add to a growing literature describing
the phenotype of arterial afferents. They express TrkA
immunoreactivity but not TrkC in adult mice and rats,
though they express Trk C transiently during development
[28]. The larger caliber arterial afferents express the hista-
mine receptor 3, which is implicated in intense pressure
mechanical nociception and allodynia [46].
We did not test for co-expression of ASIC3 with other
ASIC subunits, but the existing literature addresses this
well. ASIC3 and ASIC2, particularly the 2b splice variant,
exhibit strong overlap [21]. ASIC1 appears expressed in a
broader population of sensory neurons than is ASIC3 [21]
and it is observed in many CGRP-expressing neurons [47].
The implication that ASIC3 and ASIC1 are often in the
same cells is confirmed by both electrical and immunocy-
tochemical observations in transgenic mice [48].
Mechanosensation
Two labs have independently shown that ASICs are
present in specific non-nociceptive mechanosensory
nerve endings [7,9]. This includes ASIC3, with immuno-
reactivity observed in Aβ innervation that terminate as
Merkel endings, Meissner corpuscle endings and hair fol-
licle lanceolate endings in mice [10], as well as in rats and
monkeys (Paré and Rice, unpublished). Data here indi-
cates that 25% of ASIC3-staining cells also express TrkC, a
growth factor receptor generally associated with non-noci-
ceptive mechanosensors [30] and most clearly proven
present in muscle proprioceptors [32]. However, the fullMolecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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Muscle nociceptors more likely express ASIC3 than do skin nociceptors Figure 5
Muscle nociceptors more likely express ASIC3 than do skin nociceptors. A, Photomicrographs on the left and right 
are the same DRG section photographed for ASIC3 immunoreactivity (right) and fluorogold (left) that was retrogradely trans-
ported from injections into muscle (top) or skin (bottom). Arrows indicate cells that are 25 µm or smaller and contain both 
fluorogold and ASIC3 immunoreactivity. Scale bar, 40 µm. B, The percent of small (<25 µm) muscle or skin afferents that stain 
for ASIC3 (Immuno) or exhibit more than 0.3 nA of current evoked by a step to pH 6.8 from pH 7.4 (Ephys). 37 and 32 small 
neurons were recorded for skin and muscle, respectively. 117 and 113 small neurons were counted for skin and muscle immu-
nocytochemistry.Molecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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range of sensory modalities among TrkC expressors is
unknown. While it seems likely that the ASIC3+/TrkC+
cells include non-nociceptive mechanosensors, we cannot
be certain.
We do know for certain that the ASIC3+/TrkC+ cells are
not muscle spindle proprioceptors because they are
absent from the mesencephalic trigeminal nucleus and
they do not express parvalbumin. Other non-nociceptive
mechanosensors show a diversity of expression patterns.
Merkel cells and lanceolate endings do not express parval-
bumin [49,50], lanceolate endings express CGRP [28,49-
51], and Meissner's corpuscles express both CGRP and
P2X3 [52]. Each of these expression patterns is observed
in at least some of the ASIC3+ cells that we report. Thus,
we have no data that conflicts with the expression pattern
reported for skin mechansensory endings by Price and
colleagues [10].
Conclusion
Although less than half of all DRG sensory neurons
express ASIC3, it is in multiple populations. One popula-
tion has properties expected of metaboreceptors — cells
that detect the metabolic state of muscle, mediate com-
pensatory reflexes, and may initiate ischemic muscle pain.
Over 80% of the ASIC3-containing muscle afferents co-
express the vasodilatory peptide CGRP and some of these
innervate small arteries; these cells seem poised to modu-
late blood flow in response to muscle stress. Another pop-
ulation of ASIC3-containing cells are quite large, can
express TrkC, but do not express parvalbumin; this is a
pattern observed with some non-nociceptive mechanore-
ceptors, but may not be unique to them.
Methods
Immunocytochemistry
Young adult Sprague-Dawley rats (150 g) were deeply
anesthetized and perfused transcardially with 0.15 M
phosphate-buffered saline, pH7.4 (PBS: 150 mM NaCl,
25 mM Na2HPO4, pH 7.4) followed by approximately
300 ml 3% paraformaldehyde with 15% picric acid in PBS
or by 4% paraformaldehyde. The quality of ASIC3 stain-
ing was reduced with stronger fixation and in older rats,
which exhibited unacceptable background fluorescence.
Tissues were immediately dissected and placed in 30%
sucrose in PBS overnight, then rapidly frozen and stored
at -80°C until needed. Fourteen µm sections were cut on
a cryostat and mounted on glass slides. Slides were placed
in blocking solution containing 2% normal donkey
serum, 0.2% Triton X-100 in PBS for 30 minutes, then
incubated in primary antibody solution overnight at 4°C.
Table 1 gives dilutions of the various antisera that were
used. Next, slides were washed 3 times for 3 minutes in
PBS and incubated in secondary antibodies diluted 1:200
in blocking solution for 30 minutes. Secondary antibodies
were donkey anti-rabbit, donkey anti-mouse and donkey
anti-guinea pig conjugated to CY3 or CY2 (Jackson Immu-
noresearch, West Grove PA). Slides were washed 3 times
in PBS, mounted on coverslips in PBS and immediately
photographed. For quantification, sections were taken
from the fifth lumbar (L5) DRG. L5 was chosen because it
is the ganglion used most commonly for immunocyto-
chemistry. To minimize over-counting of large cells, only
cells showing a clear nucleus were counted. All histograms
and circle charts involved counts of over 1000 cells from
at least three rats. Immunofluorescence assessments of
arterial innervation were conducted on the lateral plantar
artery and arterioles in the lateral plantar compartment of
the foot. As described previously in detail [52], double
labeling was conducted with various combinations of pri-
mary antibodies raised in different species.
The Neuromics guinea pig ASIC3 antibody was used for
all DRG cell body experiments (Figs. 1, 2, 3, 4, 5, 6). Both
the guinea pig antibody and the rabbit ASIC3 antibody
(generous gift of Robert Elde lab) were used to label vas-
cular innervation (Figure 7 shows results with the rabbit
antibody). The presence of either antibody blocked label-
ling by the other (not shown). The antibodies were raised
against extracellular residues (237–257 for rabbit; 285–
304 for guinea pig).
Retrograde Labeling
DRG neurons innervating muscle and skin were labeled
by injecting fluorescent dyes into either quadriceps mus-
cle [53] or intradermally in the upper back between the
shoulder blades. The intradermal injection raises a small
blister that disappears within an hour; we did this in back
skin because rats scratch and bite blisters put elsewhere,
which would confound the assumption that dye is con-
fined to the injection site. DiI (Molecular Probes, Eugene,
OR. 5% in DMSO) was used for electrophysiology [54]
and fluorogold (Fluorochrome Inc, Englewood CO. 1% in
water) for immunocytochemistry because it withstands
membrane permeabilization with detergent [55]. Dye was
injected one to two weeks prior to sacrificing the rat.
Electrophysiology
Whole cell patch clamp of dissociated sensory neurons
measured currents carried by ASIC3, P2X3, or vanilloid
receptors at -70 mV holding potential, room temperature.
Solutions perfused the cells through 10 µl capillary
pipettes and were changed within 20 msec with a compu-
ter-driven solenoid valve system. We used concentrations
of ATP (50 µM) and capsaicin (1 µM) sufficient to evoke
maximal responses in P2X3 and vanilloid receptors, but
used a submaximal pH (6.8) stimulus. Because ASIC3 is
more sensitive than other rat ASICs [15], pH 6.8 triggers
ASIC3 channels without substantial activation of other
subtypes. P2X3 currents were distinguished from otherMolecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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Double-label immunofluorescence of arterial innervation among muscles in the lateral plantar compartment of the rat hind paw Figure 7
Double-label immunofluorescence of arterial innervation among muscles in the lateral plantar compartment 
of the rat hind paw. Red labeling is with secondary antibodies conjugated with Cy3, green with Cy2. The images in A and B 
are from a larger source artery and those in C-H are from smaller tributaries. L = arterial lumen, TA = tunica adventitia, TM = 
tunica media, M = skeletal muscle. Scale bar = 25 µm. A, B. Cross section of a larger artery with lumen (L) toward the right. 
Anti-CGRP (A) labeled sensory innervation that is located primarily in the tunica adventitia (green arrows). This CGRP-posi-
tive sensory innervation is supplied by axons that have thin calibers (small green arrows) and slightly thicker-calibers (large 
green arrows). Double labeling with anti-NPY (B) revealed sympathetic innervation concentrated at the border between the 
tunica media and tunica adventitia (red arrows). C, D. Cross section of an arteriole with lumen to the upper right, Muscle fib-
ers (M) in cross section below. Double staining with anti-ASIC3 (C) and anti-NF200 (D) demonstrated that ASIC3 is expressed 
primarily on the slightly thicker caliber innervation that is NF200-positive (yellow arrows). E, F. Small arterioles viewed both in 
cross section (lumen labelled L) and on edge (oval structure labelled TM). Double labeling with anti-ASIC3 (E) and anti-CGRP 
(F) revealed that ASIC3 is coexpressed exclusively with CGRP, primarily on the thicker-caliber innervation (yellow arrows). 
The smaller-caliber CGRP innervation is usually ASIC3-negative (green arrows). G, H. Edge of an artery cross section; lumen is 
out of the picture to the right; tunica media (TM) and tunica adventitia (TA) are marked. Double labeling with anti-TRPV1 (E) 
and anti-CGRP (F) demonstrated that TRPV1 is also coexpressed on the larger caliber CGRP-positive innervation (yellow 
arrows).Molecular Pain 2005, 1:35 http://www.molecularpain.com/content/1/1/35
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P2X receptors through their rapid desensitization. ATP-
Na2 was added to the external solution from a 50 mM
stock prepared in water at pH 7.4 (stored at -20°C). Cap-
saicin was prepared daily in ethanol.
Cervical or lumbar DRG were dissected and dissociated as
previously described [14], plated on glass coverslips
coated with poly-d-lysine and laminin, and maintained
for approximately 2 hr at 37°C at 5% CO2/95% air in F12
media (Gibco BRL) plus 50 ng/ml nerve growth factor
(NGF, Biomedical Tech. Inc.). Media was then changed to
L15 (Gibco BRL) plus 50 ng/ml NGF at 23°C in humidi-
fied air. Electrophysiological recordings were made 24–48
hours after dissociation. Patch pipettes were pulled from
borosilicate glass (Garner Glass, Claremont, CA) to 2.5–4
MΩ resistance. The standard internal solution contained
(in mM): 135 methane sulphonic acid, 150 KOH, 10 KCl,
8 NaCl, 1 MgCl2, 10 MOPS, 0.3 Na3-GTP, 2 ATP-Mg, and
0.5 EGTA, adjusted to pH 7.0 with KOH. The control
external solution contained (in mM): 140 NaCl, 5 KCl, 2
CaCl2, 1 MgCl2  10 HEPES, 10 MES, and 5 glucose,
adjusted to pH 7.4 with n-methyl-d-glucamine; this was
adjusted to pH 6.8 with HCl for the ASIC3-evoking solu-
tion. Data acquisition and analysis used PClamp 6.02
(Axon Instruments, Inc.) and Origin 6 (Microcal Software
Inc). Chemicals were from Sigma Co. unless otherwise
stated.
Abbreviations
ASIC, acid sensing ion channel; ASIC3ir, ASIC3 immuno-
reactivity; CGRP, neuropeptide in sensory neurons that
dilates blood vessels; DiI, a red lipophilic dye used for ret-
rograde labeling of neurons; DRG, dorsal root ganglion;
N200, neurofilament protein present mostly in myeli-
nated axons; N52, neurofilament protein present in all
sensory axons; NGF, nerve growth factor; NPY, neuropep-
tide Y; NT3, neurotrophin-3; ret, receptor for glial derived
neurotrophic factor (GDNF); P2X3, ion channel opened
by ATP; Trk A, nerve growth factor receptor; Trk C, neuro-
trophin-3 receptor; TRPV1 and VR1, ion channel opened
by capsaicin, heat, or low pH; TA, tunica adventia; TM,
tunica media
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